Location: Montreal, Quebec, Canada
CIK: 0001274413 · Show all filings
Period: Q3 2017 (← Previous) (Next →)
Filing Date: Nov 14, 2017
Total Value: $776M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| FOLD | AMICUS THERAPEUTICS | 2,412,870 | $36.39M | 4.7% | $8.13 | +62.6% | COMMON | 03152W109 |
| PFE | PFIZER INC | 957,673 | $34.19M | 4.4% | $21.41 | +3.9% | COMMON | 717081103 |
| NVS | NOVARTIS AG | 383,796 | $32.95M | 4.2% | $75.70 | — | SPNS ADR | 66987V109 |
| ACAD | ACADIA PHARMACEUTICALS | 822,392 | $30.98M | 4.0% | $27.79 | +17.1% | COMMON | 004225108 |
| JNJ | JOHNSON & JOHNSON | 235,349 | $30.6M | 3.9% | $93.62 | +12.1% | COMMON | 478160104 |
| — | PORTOLA PHARMACEUTICALS | 506,414 | $27.36M | 3.5% | $26.25 | — | COMMON | 737010108 |
| TDOC | TELADOC INC | 733,379 | $24.31M | 3.1% | $21.44 | +52.9% | COMMON | 87918A105 |
| — | LOXO ONCOLOGY INC | 245,226 | $22.59M | 2.9% | $67.28 | — | COMMON | 548862101 |
| — | ACCELERON PHARMA | 604,957 | $22.58M | 2.9% | $31.81 | — | COMMON | 00434H108 |
| BMRN | BIOMARIN PHARMAC INC | 238,413 | $22.19M | 2.9% | $80.35 | +10.0% | COMMON | 09061G101 |
| MDT | MEDTRONIC PLC | 281,160 | $21.87M | 2.8% | $67.64 | -1.0% | SHS | G5960L103 |
| — | ABIOMED INC | 128,671 | $21.69M | 2.8% | $107.42 | — | COMMON | 003654100 |
| — | LA JOLLA PHARMACEUTICAL | 601,500 | $20.92M | 2.7% | $29.88 | — | COMMON | 503459604 |
| MRK | MERCK & CO INC | 325,280 | $20.83M | 2.7% | $40.49 | +15.3% | COMMON | 58933Y105 |
| — | CLOVIS ONCOLOGY | 251,699 | $20.74M | 2.7% | $83.82 | — | COMMON | 189464100 |
| — | TESARO INC | 149,799 | $19.34M | 2.5% | $129.10 | — | COMMON | 881569107 |
| UNH | UNITEDHEALTH GRP INC | 98,205 | $19.23M | 2.5% | $168.94 | 0.0% | COMMON | 91324P102 |
| GILD | GILEAD SCIENCES INC | 234,900 | $19.03M | 2.5% | $55.94 | 0.0% | COMMON | 375558103 |
| — | K2M GROUP HOLDINGS | 896,714 | $19.02M | 2.4% | $21.16 | — | COMMON | 48273J107 |
| — | CELGENE CORP | 128,932 | $18.8M | 2.4% | $101.37 | — | COMMON | 151020104 |
| COLL | COLLEGIUM PHARMACEUTICAL | 1,749,457 | $18.35M | 2.4% | $14.15 | -22.1% | COMMON | 19459J104 |
| — | AERIE PHARMACEUTICALS | 373,396 | $18.15M | 2.3% | $36.97 | — | COMMON | 00771V108 |
| — | GLOBAL BLOOD THERAPEUTICS | 533,708 | $16.57M | 2.1% | $20.99 | — | COMMON | 37890U108 |
| ACHC | ACADIA HEALTHCARE | 329,510 | $15.74M | 2.0% | $53.40 | -8.7% | COMMON | 00404A109 |
| MOH | MOLINA HEALTHCARE | 220,359 | $15.15M | 2.0% | $65.10 | 0.0% | COMMON | 60855R100 |
| REGN | REGENERON PHARMACEUTICALS | 32,917 | $14.72M | 1.9% | $429.17 | +10.3% | COMMON | 75886F107 |
| EW | EDWARDS LIFESCIENCE | 132,580 | $14.49M | 1.9% | $31.31 | +21.8% | COMMON | 28176E108 |
| NBIX | NEUROCRINE BIOSCIENCES | 232,602 | $14.25M | 1.8% | $42.54 | +24.0% | COMMON | 64125C109 |
| PRTA | PROTHENA CORP PLC | 195,909 | $12.69M | 1.6% | $46.11 | +32.8% | SHS | G72800108 |
| EVH | EVOLENT HEALTH INC | 652,680 | $11.62M | 1.5% | $23.42 | -12.0% | COMMON | 30050B101 |
| — | SPARK THERAPEUTICS | 116,599 | $10.4M | 1.3% | $63.60 | — | COMMON | 84652J103 |
| — | WRIGHT MED GROUP N V | 373,672 | $9.667M | 1.2% | $21.59 | — | ORD SHS | N96617118 |
| IRTC | IRHYTHM TECHNOLOGIES | 185,200 | $9.608M | 1.2% | $36.42 | +24.3% | COMMON | 450056106 |
| — | CIGNA CORP | 45,615 | $8.527M | 1.1% | $180.28 | — | COMMON | 125509109 |
| — | NUVASIVE INC | 132,290 | $7.337M | 0.9% | $61.10 | — | COMMON | 670704105 |
| ZLAB | ZAI LAB LTD | 265,600 | $7.171M | 0.9% | $27.00 | — | ADR | 98887Q104 |
| IART | INTEGRA LIFESCIENCE | 140,778 | $7.106M | 0.9% | $40.68 | +26.3% | COMMON | 457985208 |
| — | MOMENTA PHARMACEUTICALS | 372,499 | $6.891M | 0.9% | $12.72 | — | COMMON | 60877T100 |
| MASI | MASIMO CORP | 72,800 | $6.302M | 0.8% | $84.91 | +4.1% | COMMON | 574795100 |
| — | NEURODERM LTD | 147,756 | $5.748M | 0.7% | $20.92 | — | ORD SHS | M74231107 |
| EXAS | EXACT SCIENCES CORP | 117,550 | $5.539M | 0.7% | $40.25 | 0.0% | COMMON | 30063P105 |
| VRTX | VERTEX PHARMACEUTICL | 34,000 | $5.169M | 0.7% | $150.51 | 0.0% | COMMON | 92532F100 |
| — | ENVISION HEALTHCARE | 113,600 | $5.106M | 0.7% | $63.25 | — | COMMON | 29414D100 |
| — | RA PHARMACEUTICALS | 278,082 | $4.06M | 0.5% | $14.98 | — | COMMON | 74933V108 |
| INCY | INCYTE CORPORATION | 33,745 | $3.939M | 0.5% | $87.22 | +45.0% | COMMON | 45337C102 |
| PTCT | PTC THERAPEUTICS I | 170,535 | $3.412M | 0.4% | $18.03 | +8.4% | COMMON | 69366J200 |
| — | ALBIREO PHARMA INC | 158,027 | $3.311M | 0.4% | $20.96 | — | COMMON | 01345P106 |
| AGIO | AGIOS PHARMACEUTICALS | 47,799 | $3.191M | 0.4% | $49.72 | +20.8% | COMMON | 00847X104 |
| — | INTEC PHARMA LTD JER | 355,000 | $3.177M | 0.4% | $8.95 | — | SHS | M53644106 |
| SRPT | SAREPTA THERAPEUTICS | 69,099 | $3.134M | 0.4% | $40.05 | -0.2% | COMMON | 803607100 |
| ARAY | ACCURAY INC | 687,547 | $2.75M | 0.4% | $5.21 | -17.6% | COMMON | 004397105 |
| — | NXSTAGE MEDICAL | 98,579 | $2.721M | 0.4% | $15.32 | — | COMMON | 67072V103 |
| — | DBV TECHNOLOGIES | 52,799 | $2.241M | 0.3% | $35.59 | — | SPNS ADR | 23306J101 |
| — | SPRING BK PHARMACEUTICALS | 123,383 | $2.078M | 0.3% | $13.83 | — | COMMON | 849431101 |
| INSM | INSMED INC | 62,399 | $1.947M | 0.3% | $14.56 | +30.8% | COMMON | 457669307 |
| ILMN | ILLUMINA INC | 9,350 | $1.863M | 0.2% | $162.61 | +14.5% | COMMON | 452327109 |
| — | OBSEVA SA | 212,831 | $1.732M | 0.2% | $9.21 | — | COMMON | H5861P103 |
| RDY | DR REDDYS LABS LTD | 45,796 | $1.634M | 0.2% | $40.05 | — | ADR | 256135203 |
| — | TRILLIUM THERAPEUTCS | 234,248 | $1.206M | 0.2% | $5.31 | — | COMMON | 89620X506 |
| TGTX | TG THERAPEUTICS | 100,366 | $1.189M | 0.2% | $7.98 | +42.7% | COMMON | 88322Q108 |
| — | CLEMENTIA PHARMACEUT | 30,313 | $512K | 0.1% | $16.89 | — | COMMON | 185575107 |
| — | SIERRA ONCOLOGY INC | 201,660 | $313K | 0.0% | $1.53 | — | COMMON | 82640U107 |